Description

This research service analyzes the market for prenatal testing with market sizing and forecasts for laboratory service revenues, which are typically reimbursed by the patient's insurance, fee-for-service, or institutional contracts. In this analysis, prenatal testing revenues include the use of clinical laboratory technologies in prenatal applications for detection of chromosomal imbalances and procedures for nuchal translucency prenatal ultrasound. Prenatal testing revenues exclude fetal anatomy ultrasound procedures, single-gene disorders and other inherited diseases, clinical prenatal lab testing using noninvasive prenatal diagnostic technologies, carrier testing, neonatal or postnatal testing, and preimplantation genetic diagnosis.